{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0090303",
      "entity_text" : "injury",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P37231",
      "entity_text" : "PPAR-gamma",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "The PPAR-gamma ligand, troglitazone, has been shown to markedly decrease the severity of pancreatic and pulmonary injury in acute pancreatitis (AP) by reversing the increase in the mRNA expression of the pro inflammatory cytokines, interleukin (IL) -6 and tumor necrosis factor (TNF)-alpha, in cerulean induced pancreatitis in mice.",
  "reading_complete" : "2020-08-02T15:43:52Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T15:42:30Z",
  "trigger" : "decrease",
  "evidence" : [ "PPAR-gamma ligand, troglitazone, has been shown to markedly decrease the severity of pancreatic and pulmonary injury" ],
  "pmc_id" : "3782553",
  "score" : 0
}